Skip to content

The PCOS Challenge Study

The PCOS Challenge Study: For the Collection of Information to Advance Research and Improve Care for PCOS Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05797909
Acronym
PCOSCHALLENGE
Enrollment
15000
Registered
2023-04-04
Start date
2022-06-22
Completion date
2042-12-31
Last updated
2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Keywords

pcos, polycystic ovary syndrome, polycystic ovarian syndrome, stein leventhal syndrome

Brief summary

The primary purpose of The PCOS Challenge Study will be to conduct high-quality research where patients are included in the design, and answering the questions that patients identify as important to their lived experience with PCOS. In partnership with clinical investigators, patients will work on the development and management of data collection, the research agenda, and the sharing of research findings. The PCOSC Study will promote the advancement of research that provides reliable, useful, and meaningful information to patients with PCOS and their clinicians. The population for The PCOS Challenge Study will include individuals with a clinical diagnosis of PCOS, individuals self-diagnosed with PCOS, individuals with symptoms of PCOS (e.g., hirsutism, irregular menstrual cycles), and demographic-matched controls without PCOS.

Interventions

None listed

Sponsors

PCOS Challenge: The National Polycystic Ovary Syndrome Association
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
12 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed with PCOS by a health professional, self-diagnosed with PCOS or individuals with PCOS symptoms * Willing to sign the consent form * Able to understand the registry surveys or what is being asked

Exclusion criteria

* Unable to understand the surveys or what is being asked * Unwilling to sign the consent form

Design outcomes

Primary

MeasureTime frameDescription
InformationOne YearSuch as responses to survey questions

Countries

United States

Contacts

Primary ContactSasha Ottey, MHA, MT (ASCP)
info@pcoschallenge.org(404) 855-7244

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026